Skip to main content
Top
Published in: Rheumatology International 2/2018

Open Access 01-02-2018 | Public Health

Secular trends in sickness absence among Swedish patients with ankylosing spondylitis and psoriatic arthritis

Authors: Christel Nielsen, Ingemar F. Petersson, Lennart T. H. Jacobsson, Anna Jöud

Published in: Rheumatology International | Issue 2/2018

Login to get access

Abstract

The aim was to investigate whether secular trends in sickness absence (SA) were present in patients with ankylosing spondylitis (AS) and psoriatic arthritis (PsA) receiving their diagnosis between 2002 and 2011. A repeated cross-sectional study design was used. Patients were identified in the Skåne Healthcare Register (SHR). A washout period of 18 months was applied. The general population seeking health care was used as a reference cohort. SA data from 2003 to 2012 were obtained from the Swedish Social Insurance Agency and converted into net days of SA per year. Within diagnosis and sex, the average number of net days of SA during the calendar year following diagnosis was calculated and plotted against calendar year together with the corresponding SA of the age-standardized reference population. Linear regression on aggregated data, within diagnosis and sex, was applied to formally investigate differences in secular trends among patients and referents. There were 3173 patients and 992,502 referents. Among men diagnosed with AS, the average amount of SA declined by 8.1 net days per year in patients as compared with 2.4 in the referents (p = 0.01). Among PsA patients, the average amount of SA declined by 11.7 net days per year in women as compared with 2.7 in the referents (p < 0.001) and by 7.6 net days per year in men as compared with 1.9 in the referents (p < 0.001). Secular trends of declining SA were present among AS and PsA patients. Trends were also present among the referents, although not at all of the same magnitude.
Literature
1.
go back to reference Heikkilä S, Viitanen JV, Kautiainen H, Kauppi M (2002) Functional long-term changes in patients with spondylarthropathy. Clin Rheumatol 21:119–122CrossRefPubMed Heikkilä S, Viitanen JV, Kautiainen H, Kauppi M (2002) Functional long-term changes in patients with spondylarthropathy. Clin Rheumatol 21:119–122CrossRefPubMed
3.
go back to reference Bremander A, Petersson IF, Bergman S, Englund M (2011) Population-based estimates of common comorbidities and cardiovascular disease in ankylosing spondylitis. Arthritis Care Res 63:550–556. doi:10.1002/acr.20408 CrossRef Bremander A, Petersson IF, Bergman S, Englund M (2011) Population-based estimates of common comorbidities and cardiovascular disease in ankylosing spondylitis. Arthritis Care Res 63:550–556. doi:10.​1002/​acr.​20408 CrossRef
4.
go back to reference Han C, Robinson DW, Hackett MV et al (2006) Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J Rheumatol 33:2167–2172PubMed Han C, Robinson DW, Hackett MV et al (2006) Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J Rheumatol 33:2167–2172PubMed
5.
go back to reference Horreau C, Pouplard C, Brenaut E et al (2013) Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review. J Eur Acad Dermatol Venereol 27(Suppl 3):12–29. doi:10.1111/jdv.12163 CrossRefPubMed Horreau C, Pouplard C, Brenaut E et al (2013) Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review. J Eur Acad Dermatol Venereol 27(Suppl 3):12–29. doi:10.​1111/​jdv.​12163 CrossRefPubMed
8.
go back to reference Rohekar S, Pope J (2010) Assessment of work disability in seronegative spondyloarthritis. Clin Exp Rheumatol 28:35–40PubMed Rohekar S, Pope J (2010) Assessment of work disability in seronegative spondyloarthritis. Clin Exp Rheumatol 28:35–40PubMed
9.
go back to reference Strömbeck B, Englund M, Bremander A et al (2010) Cost of illness from the public payers’ perspective in patients with ankylosing spondylitis in rheumatological care. J Rheumatol 37:2348–2355. doi:10.3899/jrheum.100099 CrossRefPubMed Strömbeck B, Englund M, Bremander A et al (2010) Cost of illness from the public payers’ perspective in patients with ankylosing spondylitis in rheumatological care. J Rheumatol 37:2348–2355. doi:10.​3899/​jrheum.​100099 CrossRefPubMed
10.
go back to reference Carlsson L, Lännerström L, Wallman T, Holmström IK (2015) General practitioners’ perceptions of working with the certification of sickness absences following changes in the Swedish social security system: a qualitative focus-group study. BMC Fam Pract 16:21. doi:10.1186/s12875-015-0238-5 CrossRefPubMedPubMedCentral Carlsson L, Lännerström L, Wallman T, Holmström IK (2015) General practitioners’ perceptions of working with the certification of sickness absences following changes in the Swedish social security system: a qualitative focus-group study. BMC Fam Pract 16:21. doi:10.​1186/​s12875-015-0238-5 CrossRefPubMedPubMedCentral
12.
go back to reference Maxwell LJ, Zochling J, Boonen A, et al (2015) TNF-alpha inhibitors for ankylosing spondylitis. Cochrane Database Syst Rev CD005468. doi:10.1002/14651858.CD005468.pub2 Maxwell LJ, Zochling J, Boonen A, et al (2015) TNF-alpha inhibitors for ankylosing spondylitis. Cochrane Database Syst Rev CD005468. doi:10.1002/14651858.CD005468.pub2
13.
go back to reference Lemos LLP, de Oliveira Costa J, Almeida AM et al (2014) Treatment of psoriatic arthritis with anti-TNF agents: a systematic review and meta-analysis of efficacy, effectiveness and safety. Rheumatol Int 34:1345–1360. doi:10.1007/s00296-014-3006-2 CrossRefPubMed Lemos LLP, de Oliveira Costa J, Almeida AM et al (2014) Treatment of psoriatic arthritis with anti-TNF agents: a systematic review and meta-analysis of efficacy, effectiveness and safety. Rheumatol Int 34:1345–1360. doi:10.​1007/​s00296-014-3006-2 CrossRefPubMed
14.
go back to reference Kristensen LE, Petersson IF, Geborek P et al (2012) Sick leave in patients with ankylosing spondylitis before and after anti-TNF therapy: a population-based cohort study. Rheumatol Oxf Engl 51:243–249. doi:10.1093/rheumatology/ker169 CrossRef Kristensen LE, Petersson IF, Geborek P et al (2012) Sick leave in patients with ankylosing spondylitis before and after anti-TNF therapy: a population-based cohort study. Rheumatol Oxf Engl 51:243–249. doi:10.​1093/​rheumatology/​ker169 CrossRef
17.
go back to reference Kristensen LE, Englund M, Neovius M et al (2013) Long-term work disability in patients with psoriatic arthritis treated with anti-tumour necrosis factor: a population-based regional Swedish cohort study. Ann Rheum Dis 72:1675–1679. doi:10.1136/annrheumdis-2012-202229 CrossRefPubMed Kristensen LE, Englund M, Neovius M et al (2013) Long-term work disability in patients with psoriatic arthritis treated with anti-tumour necrosis factor: a population-based regional Swedish cohort study. Ann Rheum Dis 72:1675–1679. doi:10.​1136/​annrheumdis-2012-202229 CrossRefPubMed
18.
go back to reference Sørensen J, Hetland ML, on behalf of all departments of rheumatology in Denmark (2014) Diagnostic delay in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis: results from the Danish nationwide DANBIO registry. Ann Rheum Dis. doi:10.1136/annrheumdis-2013-204867 PubMedCentral Sørensen J, Hetland ML, on behalf of all departments of rheumatology in Denmark (2014) Diagnostic delay in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis: results from the Danish nationwide DANBIO registry. Ann Rheum Dis. doi:10.​1136/​annrheumdis-2013-204867 PubMedCentral
Metadata
Title
Secular trends in sickness absence among Swedish patients with ankylosing spondylitis and psoriatic arthritis
Authors
Christel Nielsen
Ingemar F. Petersson
Lennart T. H. Jacobsson
Anna Jöud
Publication date
01-02-2018
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 2/2018
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-017-3809-z

Other articles of this Issue 2/2018

Rheumatology International 2/2018 Go to the issue